Enhancement of intranasal absorption of calcitonin by formulation with surfactants.

摘要

A pharmaceutical composition for the treatment of disorders of bone metabolism which comprises an aqueous or non-aqueous medium suitable for intranasal administration and containing a therapeutically effective amount of colcitonin and a surface active agent.